%0 Journal Article
%A Castelli, Sveva
%A Schulze, Franziska
%A Thole-Kliesch, Theresa M
%A Astrahantseff, Kathy
%A Barone, Giuseppe
%A Beck-Popovic, Maja
%A Berlanga, Pablo
%A Corbacioglu, Selim
%A Fischer, Matthias
%A Gambart, Marion
%A George, Sally L
%A Chesler, Louis
%A Gray, Juliet C
%A Hero, Barbara
%A Künkele, Annette
%A Flaadt, Tim
%A Lang, Peter
%A Lode, Holger N
%A Molenaar, Jan J
%A Schleiermacher, Gudrun
%A Rosswog, Carolina
%A Moreno, Lucas
%A Owens, Cormac
%A Rubio-San-Simón, Alba
%A Schulte, Johannes
%A Simon, Thorsten
%A Tweddle, Deborah A
%A Deubzer, Hedwig E
%A Eggert, Angelika
%A SIOPEN New Drug Development, Immunotherapy
%T Current treatment strategies for first relapse of high-risk neuroblastoma.
%J European journal of cancer
%V 236
%@ 0959-8049
%C Amsterdam [u.a.]
%I Elsevier
%M DKFZ-2026-00293
%P 116254
%D 2026
%Z #DKTKZFB26#
%X More than 50 
%K Anaplastic lymphoma kinase (Other)
%K CAR T cells (Other)
%K Camptothecins (Other)
%K Chemoimmunotherapy (Other)
%K Disialoganglioside GD2 (Other)
%K Embryonal tumor (Other)
%K Haplo-SCT (Other)
%K Molecular tumor board (Other)
%K Pediatric cancer (Other)
%K Precision medicine (Other)
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:41643518
%R 10.1016/j.ejca.2026.116254
%U https://inrepo02.dkfz.de/record/309671